BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines gAAP Gross Margin (% of Global Product Sales) (%)
Form 8-K EX-99.1 Earnings Releases & Form 10-Q / 10-K MD&A
Latest, FY2025
87.3%
Period ended Dec 31, 2025
Change on a year earlier
+3.0 pts
84.3% in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Gross Margin (% of Global Product Sales) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 87.3% | +3.0 pts | Form 8-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 84.3% | +1.6 pts | Form 8-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 82.7% | +5.5 pts | Form 8-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 77.2% | +3.2 pts | Form 8-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 74.0% | – | Form 8-K (filed 2023-02-27) ↗ |
Breakdown
What makes up gaap gross margin (% of global product sales)
Cite this data
StockData. (2026). BeOne Medicines GAAP Gross Margin (% of Global Product Sales) (%), annual FY2021–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/gaap_gm_pct
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.